Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Temozolomide × 30 days × Clear all

Sponsor

Conditions

Glioblastoma 22 Glioma 12 Sarcoma, Ewing 7 Brain Neoplasms 7 Gliosarcoma 6 Astrocytoma 6 Sarcoma 4 Rhabdomyosarcoma 4 Recurrence 3 Osteosarcoma 3 Neoplasm Metastasis 3 Medulloblastoma 3 Ependymoma 3 Diffuse Intrinsic Pontine Glioma 3 Small Cell Lung Carcinoma 2 Neuroblastoma 2 Lymphoma, Follicular 2 Lymphoma 2 Desmoplastic Small Round Cell Tumor 2 Colorectal Neoplasms 2 Wilms Tumor 1 Somatostatinoma 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1

Interventions

Bevacizumab 13 atezolizumab 12 Specimen Handling 9 Nivolumab 8 durvalumab 6 pembrolizumab 4 X-Rays 4 Radiosurgery 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 lenvatinib 3 Sorafenib 3 Immunoglobulin G 3 E-7386 3 Cyclophosphamide 3 Blood Specimen Collection 3 sintilimab 2 regorafenib 2 cabozantinib 2 Disulfides 2 Biopsy 2 tremelimumab 1 tislelizumab 1 sofosbuvir-velpatasvir drug combination 1 sargramostim 1 sapanisertib 1 rocakinogene sifuplasmid 1 relatlimab 1 recombinant interferon alpha 2b-like protein 1 fludarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡